Carson Wealth (CWM LLC)’s Filana Therapeutics FLNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$769 Hold
455
﹤0.01% 5435
2025
Q4
$1K Sell
455
-136
-23% -$435 ﹤0.01% 5273
2025
Q3
$2K Sell
591
-858
-59% -$1.97K ﹤0.01% 5038
2025
Q2
$3K Sell
1,449
-3,448
-70% -$6.13K ﹤0.01% 4807
2025
Q1
$7K Buy
4,897
+4,413
+912% +$11.1K ﹤0.01% 4312
2024
Q4
$1K Buy
484
+184
+61% +$3.23K ﹤0.01% 4789
2024
Q3
$9K Buy
300
+10
+3% +$230 ﹤0.01% 3853
2024
Q2
$4K Buy
290
+30
+12% +$632 ﹤0.01% 4000
2024
Q1
$5K Buy
+260
New +$5.99K ﹤0.01% 3687
2023
Q4
Sell
-14
Closed 4473
2023
Q3
$0 Sell
14
-264
-95% -$5.23K ﹤0.01% 4494
2023
Q2
$7K Hold
278
﹤0.01% 3301
2023
Q1
$7K Hold
278
﹤0.01% 3161
2022
Q4
$8K Hold
278
﹤0.01% 2955
2022
Q3
$12K Hold
278
﹤0.01% 2587
2022
Q2
$8K Hold
278
﹤0.01% 2731
2022
Q1
$10K Buy
+278
New +$11.8K ﹤0.01% 2492
2021
Q2
$17K Hold
200
﹤0.01% 1875
2021
Q1
$17K Hold
200
﹤0.01% 1875
2020
Q4
$17K Hold
200
﹤0.01% 1874
2020
Q3
$17K Hold
200
﹤0.01% 1874
2020
Q2
$17K Hold
200
﹤0.01% 1874
2020
Q1
$17K Hold
200
﹤0.01% 1874
2019
Q4
$17K Hold
200
﹤0.01% 1873
2019
Q3
$17K Hold
200
﹤0.01% 1873
2019
Q2
$17K Hold
200
﹤0.01% 1873
2019
Q1
$17K Buy
+200
New +$229 ﹤0.01% 1873

Other funds holding FLNA

Carson Wealth (CWM LLC)'s FLNA Position: Q1 2026 in Review

Carson Wealth (CWM LLC) held its Filana Therapeutics (FLNA) position steady in Q1 2026 at 455 shares worth $769. The position accounts for ﹤0.01% of the portfolio, ranked #5435.

Carson Wealth (CWM LLC) first reported a position in FLNA in Q1 2019 and has held it in 26 quarters since. The position peaked at $17K in Q2 2021. 101 funds tracked by Wall St. Rank hold FLNA as of Q1 2026.

  • Carson Wealth (CWM LLC) held 455 shares of Filana Therapeutics worth $769 as of Q1 2026.
  • Carson Wealth (CWM LLC) left its Filana Therapeutics share count unchanged in Q1 2026.
  • Filana Therapeutics made up ﹤0.01% of Carson Wealth (CWM LLC)'s portfolio in Q1 2026, its #5435 holding.
  • Carson Wealth (CWM LLC) first reported a position in Filana Therapeutics in Q1 2019 and has held it in 26 quarters since.
  • Carson Wealth (CWM LLC)'s Filana Therapeutics position peaked at $17K in Q2 2021.
  • 101 funds tracked by Wall St. Rank held Filana Therapeutics as of Q1 2026.

Based on Carson Wealth (CWM LLC)'s 13F filing for Q1 2026, filed 14 May 2026.